How to avoid pharmaceuticals in the aquatic environment

Larsen, Tove A.; Lienert, Judit; Joss, Adriano; Siegrist, Hansruedi

doi:10.1016/j.jbiotec.2004.03.033

Cited by 182 publications

(89 citation statements)

References 45 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…However, as well as removing micro pollutants, ozone reduces not only the microbial count but also odour, colour and foam. At the same time, it is associated with higher energy costs as described above (Larsen et al, 2004).…”

Section: Ozonationmentioning

confidence: 99%

“…Ozone production is an energy intensive process, making it costly to implement. An ozone treatment system may increase the energy demand over a conventional wastewater treatment plant by 40-50 % (Larsen et al, 2004). The use of ozone as a means of breaking down pharmaceuticals in water has been the subject of numerous studies over the last ten years including (Andreozzi et al, 2003a;b;Vogna et al, 2004a;b).…”

Section: Ozonationmentioning

confidence: 99%

See 1 more Smart Citation

Treatment options for wastewater effluents from pharmaceutical companies

Deegan

Basha

Nolan

et al. 2011

Int. J. Environ. Sci. Technol.

295

126

View full text Add to dashboard Cite

Section: Ozonationmentioning

confidence: 99%

Section: Ozonationmentioning

confidence: 99%

Treatment options for wastewater effluents from pharmaceutical companies

Deegan

Basha

Nolan

et al. 2011

Int. J. Environ. Sci. Technol.

295

126

View full text Add to dashboard Cite

“…This system is actually being widely used for wastewater treatment, as it allows smaller sludge aeration basin volume, exceeds significantly the efficiency of conventional sand filtration and presents higher SRTs above the levels that can be obtained with secondary clarifiers [1,36]. However, removal efficiencies of the target compounds obtained by this treatment system were also insufficient ( Table 2).…”

Section: Occurrence and Removal Of Target Analyses Through Activated mentioning

confidence: 99%

Upgrading of Wastewater Treatment Plants Through the Use of Unconventional Treatment Technologies: Removal of Lidocaine, Tramadol, Venlafaxine and Their Metabolites

Rúa-Gómez

Guedez

Ania

et al. 2012

Water

View full text Add to dashboard Cite

Abstract:The occurrence and removal efficiencies of the pharmaceuticals lidocaine (LDC), tramadol (TRA) and venlafaxine (VEN), and their major active metabolites monoethylglycinexylidide (MEGX), O-desmethyltramadol (ODT) and O-desmethylvenlafaxine (ODV) were studied at four wastewater treatment plants (WWTPs) equipped with activated sludge treatment technologies. In parallel to activated sludge treatment, the removal efficiency of the compounds in pilot-and full-scale projects installed at the WWTPs was investigated. Within these projects two different treatment methods were tested: adsorption onto powdered/granulated activated carbon (PAC/GAC) and ozonation. The metabolite MEGX was not detected in any sample. The concentrations of the target analytes in wastewater effluents resulting from activated sludge treatment ranged from 55 to 183 (LDC), 88 to 416 (TRA), 50 to 245 (ODT), 22 to 176 (VEN) and 77 to 520 ng L −1 (ODV). In the pilot project with subsequent treatment with PAC/GAC, the mean concentrations of the analytes were between

show abstract

“…Several reviews dealing with the exposition and effect of pharmaceuticals have been published recently (Halling-Sorensen et al, 1998;Daughton and Ternes, 1999;Jorgensen and Halling-Sorensen 2000;Kümmerer, 2001;Petrovic et al, 2003;Larsen et al, 2004;Janex-Habibi et al, 2004;Jones et al, 2004;Kuster et al, 2004;Zwiener and Frimmel 2004;Garric and Ferrari, 2005;Hernando et al, 2005;Fent et al, 2006;Zuccato et al, 2006). These reviews allow to identify more than one hundred pharmaceuticals and personal care Environmental Pollution, vol.…”

Section: Introductionmentioning

confidence: 99%

“…Several papers present ranges of PPCPs concentrations in various compartments of the aquatic environment and in wastewaters (Halling-Sorensen, 1998;Daughton and Ternes, 1999;Kümmerer, 2001;Garric and Ferrari, 2005;Fent et al, 2006). Finally, a few papers present and compare the various processes used in WWTPs to eliminate PPCPs (Janex-Habibi et al, 2004;Larsen et al, 2004). Larsen et al (2004) presented the source separation approach, which consists of pre-treatment of highly contaminated sources such as urines or wastewaters from hospitals.…”

Section: Introductionmentioning

confidence: 99%

Fate of pharmaceuticals and personal care products in wastewater treatment plants – Conception of a database and first results

Miège¹,

Choubert²,

Ribeiro³

et al. 2009

Environmental Pollution

622

209

View full text Add to dashboard Cite

By means of a database including information from 117 international scientific papers, we present quantitative conclusions on the concentrations, frequencies of detection and removals of pharmaceutical products in wastewater treatment plants. Abstract:We created a database in order to quantitatively assess the occurrence and removal efficiency of pharmaceuticals and personal care products (PPCPs) in wastewater treatment plants (WWTPs). From 117 scientific publications, we compiled 6641 data covering 184 PPCPs. Data included the concentrations of PPCPs in WWTP influents and effluents, their removal efficiency and their loads to the aquatic environment. The first outputs of our database allowed to identify the most investigated PPCPs in WWTPs and the most persistent ones, and to obtain reliable and quantitative values on their concentrations, frequency of detection and removal efficiency in WWTPs. We were also able to compare various processes and pointed out activated sludge with nitrogen treatment and membrane bioreactor as the most efficient ones.

show abstract

How to avoid pharmaceuticals in the aquatic environment

Cited by 182 publications

References 45 publications

Treatment options for wastewater effluents from pharmaceutical companies

Treatment options for wastewater effluents from pharmaceutical companies

Upgrading of Wastewater Treatment Plants Through the Use of Unconventional Treatment Technologies: Removal of Lidocaine, Tramadol, Venlafaxine and Their Metabolites

Fate of pharmaceuticals and personal care products in wastewater treatment plants – Conception of a database and first results

Contact Info

Product

Resources

About